Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides

Antimicrobial Agents and Chemotherapy

Volumn 46, Issue 9, 2002, Pages 2885-2888

  Giacometti, Andrea ^a   Cirioni, Oscar ^a   Ghiselli, Roberto ^a   Orlando, Fiorenza ^a   Mocchegiani, Federico ^a   Riva, Alessandra ^a   Del Prete, Maria Simona ^a   Saba, Vittorio ^a   Scalise, Giorgio ^a  

^a Ospedale Regionale Torrette   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DALFOPRISTIN PLUS QUINUPRISTIN; GLYCOPEPTIDE; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL GROWTH; BACTERICIDAL ACTIVITY; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BLOOD VESSEL GRAFT; COLONY FORMING UNIT; CONTROLLED STUDY; DACRON IMPLANT; DRUG ACTIVITY; DRUG EFFICACY; GRAFT INFECTION; GROWTH INHIBITION; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PRIORITY JOURNAL; RAT; STAPHYLOCOCCUS EPIDERMIDIS;

ANIMALS; ANTI-BACTERIAL AGENTS; BLOOD VESSEL PROSTHESIS; DRUG RESISTANCE, MICROBIAL; MALE; MICROBIAL SENSITIVITY TESTS; PROSTHESIS-RELATED INFECTIONS; RATS; RATS, WISTAR; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS EPIDERMIDIS; VANCOMYCIN RESISTANCE; VIRGINIAMYCIN;

EID: 0036720603     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.46.9.2885-2888.2002     Document Type: Article

References (27)

1. Expanded application of in situ replacement for prosthetic graft infection
2. The natural history of bacterial biofilm graft infection
3. Prophylactic antibiotics prevent bacterial biofilm graft infection
4. Prevention of graft infection by use of prostheses bonded with a rifampin collagen release system
5. The critical relationship of antibiotic dose and bacterial contamination in experimental infection
6. Experimental treatment of vascular graft infection due to Staphylococcus epidermidis by in situ replacement with a rifampin-bonded polyester graft
7. Interactions of quinupristin-dalfopristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalfopristin alone was not bactericidal
8. Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft
9. Antibiotic bonding to polytetrafluoroethylene with tridodecylmethylammonium chloride
10. Current opinion in prosthetic vascular graft infection
11. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin
12. Observations on the risk of resistance with the extended use of vancomycin
13. Prophylaxis of local vascular graft infection with levofloxacin incorporated into albumin-sealed Dacron graft
14. Modification of the polyethylene terephthalate (Dacron) via denier reduction: Effects on material tensile strength, weight, and protein binding capabilities
15. Quinupristin/dalfopristin (RP 59500) therapy for vancomycin resistant Enterococcus faecium aortic graft infection: Case report
16. Peritonitis due to vancomycin-resistant Staphylococcus epidermidis
17. Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-sealed Dacron
18. Rifampicin impregnated Dacron grafts: No development of rifampicin resistance in an animal model
19. Emergence of vancomycin resistance in coagulase-negative staphylococci
20. Prevention of vascular prosthetic infection with an antibiotic-bonded Dacron graft
21. Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci
22. An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduces the incidence of subsequent graft infections following a staphylococcal challenge
23. Current perspectives on glycopeptide resistance
24. Prevention of vascular graft infection by sisomicin incorporated into fibrin glue
25. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics